Washington DC
,
USA
21 - 25 June 2025
International Society on Thrombosis and Haemostasis, 2025, (ISTH)
Presentation schedule and materials
Saturday, 21 June 2025
13:00
- 13:15
EDT
OC 03.1
ORAL PRESENTATION
Mim8 enhances procoagulant activity of select hemophilia B-causing factor IX variants
Sebastian Leyes Porello1; Kyumin Lee1; Jacob Lund3; Benjamin Samelson-Jones1,2
MATERIALS AVAILABLE
Coming soon
Sunday, 22 June 2025
15:30
- 15:45
EDT
OC 20.4
ORAL PRESENTATION
FRONTIER5 direct switch study: Safety of initiating Mim8 prophylaxis without washout of Emicizumab
Johannes Oldenburg1*; Gary Benson2; Pratima Chowdary3; Robert Klamroth4,5; Anne Lienhart6; Davide Matino7; Camila Martins Mazini Tavares8 Keiji Nogami9 Flora Peyvandi10,11; Amalie Rhode Høgh Nielsen8; Guy Young12; Allison P Wheeler13
MATERIALS AVAILABLE
Coming soon
Monday, 23 June 2025
13:45
- 14:45
EDT
PB0851
POSTER
Non-joint bleeds in patients with hemophilia A or B with inhibitors: Concizumab explorer7 study
Amy Shapiro1;Ana Boban2; Renée Brown Frandsen3; Giancarlo Castaman4; Kingsley Hampton5; Keiji Nogami6; Jameela Sathar7; Senthil Vel3; Jerzy Windyga8; Victor Jimenez Yuste9
MATERIALS AVAILABLE
Coming soon
13:45
- 14:45
EDT
PB0812
POSTER
Evaluating pen-injector handling and PROs in patients switching from emicizumab to Mim8 in FRONTIER5
Johnny Mahlangu1; Sanjay Ahuja2; Erin Cockrell3; Víctor Jiménez-Yuste4; Michele Schiavulli5; Amalie Rhode Høgh Nielsen6; Camila Martins Mazini Tavares6; Cédric Hermans7
MATERIALS AVAILABLE
Coming soon
15:45
- 16:00
EDT
OC 39.5
ORAL PRESENTATION
In vitro activity of Inno8 in global hemostatic assays alone and with other hemostatic agents.
Jacob Lund1; Kasper Jensen2; Mirella Ezban1
MATERIALS AVAILABLE
Coming soon
Tuesday, 24 June 2025
09:45
- 10:00
EDT
OC 51.2
ORAL PRESENTATION
Genomic integration of FVIII transgene in hepatocytes restores durable FVIII activity in vivo
Jacob Lund1; John Moore2; Carsten Dan Ley1; Karl Agger2; Christopher William Smith1; Jesper Tranekær Jørgensen1; Michelle Scalley Kim2; Jazz Hallinan2; Kendall Sanson2; Rikke Hvid Lindecrona1; Lene Diness Jensen1; Nadin Jahnke2; Gert Bolt3; Erin Louise Brown2; Jonas Ahnfelt-Rønne1; Esther Bloem3; Jonas Højfeldt2; Karina Thorn2 and Gro Klitgaard Povlsen1
MATERIALS AVAILABLE
Coming soon
12:15
- 13:30
EDT
Symposium
Striving towards optimal hemophilia care through patient-centric approaches
Guy Young (USA)
;
Margareth Ozelo (Brazil)
;
Carmen Escuriola Ettingshausen (Germany)
;
Radoslaw Kaczmarek (USA)
MATERIALS AVAILABLE
Coming soon
13:45
- 14:45
EDT
PB1423
POSTER
Joint bleed diagnosis and treatment delays in people with hemophilia: Global real-world data
Flora Peyvandi1; Neil Reynolds2; Olivera Rajkovic-Hooley2;Cléa Percier3; Leonardo Gottlob3; Roberta Gualtierotti1
MATERIALS AVAILABLE
Coming soon
13:45
- 14:45
EDT
PB1485
POSTER
US physician-reported prophylactic treatment satisfaction and joint health of people with hemophilia
lnara Fazio-Eynullayeva1; Cléa Percier2; Nathan Ball3; Kieran WynneCattanach3
MATERIALS AVAILABLE
Coming soon
13:45
- 14:45
EDT
PB1478
POSTER
The effect of Concizumab on thrombin generation in FVII deficient plasma
Marianne Kjalke1
MATERIALS AVAILABLE
Coming soon
15:00
- 15:15
EDT
OC 59.2
ORAL PRESENTATION
Annualized bleeding rates in hemophilia A/B and target joints: Concizumab explorer8 study
Allison P Wheeler1; Pantep Angchaisuksiri2; Shashikant Apte3; Gary Benson4; Renée Brown Frandsen5; Anthony KC Chan6; Hermann Eichler7; Teruhisa Fujii8; Mohamed Salim Nekkal9; Sonata Šaulytė Trakymienė10; Alice Trinchero11; Senthil Vel5 and Jan Astermark12;
MATERIALS AVAILABLE
Coming soon
Keywords